Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Guilhamon

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Nature Communications|February 5, 2025
OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastomaKinjal Desai, Siyi Wanggou, Erika Luis, et al.
Cell Reports|December 7, 2017
Convergence of BMI1 and CHD7 on ERK Signaling in MedulloblastomaSara Badodi, Adrian Dubuc, Xinyu Zhang, et al.
Cancer Cell|November 19, 2019
Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate TumorsParisa Mazrooei, Ken J Kron, Yanyun Zhu, et al.
Cancer Discovery|June 18, 2020
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast CancerGeneviève Deblois, Seyed Ali Madani Tonekaboni, Giacomo Grillo, et al.
Cell Stem Cell|July 18, 2017
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem CellsNicole I Park, Paul Guilhamon, Kinjal Desai, et al.
Cell Stem Cell|September 9, 2017
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem CellsNicole I Park, Paul Guilhamon, Kinjal Desai, et al.
Genome Research|June 29, 2019
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastomaMichael J Johnston, Ana Nikolic, Nicoletta Ninkovic, et al.
Elife|January 11, 2021
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survivalPaul Guilhamon, Charles Chesnelong, Michelle M Kushida, et al.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cancer Cell|September 19, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Nature Communications|February 5, 2025
OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastomaKinjal Desai, Siyi Wanggou, Erika Luis, et al.
Cell Reports|December 7, 2017
Convergence of BMI1 and CHD7 on ERK Signaling in MedulloblastomaSara Badodi, Adrian Dubuc, Xinyu Zhang, et al.
Cancer Cell|November 19, 2019
Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate TumorsParisa Mazrooei, Ken J Kron, Yanyun Zhu, et al.
Cancer Discovery|June 18, 2020
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast CancerGeneviève Deblois, Seyed Ali Madani Tonekaboni, Giacomo Grillo, et al.
Cell Stem Cell|July 18, 2017
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem CellsNicole I Park, Paul Guilhamon, Kinjal Desai, et al.
Cell Stem Cell|September 9, 2017
ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem CellsNicole I Park, Paul Guilhamon, Kinjal Desai, et al.
Genome Research|June 29, 2019
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastomaMichael J Johnston, Ana Nikolic, Nicoletta Ninkovic, et al.
Elife|January 11, 2021
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survivalPaul Guilhamon, Charles Chesnelong, Michelle M Kushida, et al.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cancer Cell|September 19, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Pageof 3